← Back to Clinical Trials
Recruiting NCT07002944

NCT07002944 Pulsed Radiofrequency of Shoulder Individual Nerves Versus Brachial Plexus in Management of Chronic Post Mastectomy Shoulder Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07002944
Status Recruiting
Phase
Sponsor Cairo University
Condition Pulsed Radiofrequency
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2025-06-03
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Brachial plexus pulsed radiofrequencySholder individual nerves pulsed radiofrequencyControl

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2025-06-03 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

this study aims to assess the role of pulsed radiofrequency of the brachial plexus or pulsed radiofrequency of shoulder individual nerves in the management of post-mastectomy shoulder pain.

Eligibility Criteria

Inclusion Criteria: * Age (18-65) Years. * American Society of Anesthesiologists (ASA) physical status (II- III). * Patients with post mastectomy shoulder pain. * Body mass index (BMI): (20-40) kg/m2. * Patients on maximum daily dose tramadol ( 450mg ) and still in pain Exclusion Criteria: * Patient refusal. * Known sensitivity or contraindication to drugs used in the study. * Pregnancy. * Recent myocardial infarction. * Hemodynamically unstable. * Local and systemic sepsis. * Psychiatric illness.

Contact & Investigator

Central Contact

Yasmina S Ismail, Master

✉ Yasminasayed.Ys@icloud.com

📞 00201223014453

Frequently Asked Questions

Who can join the NCT07002944 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Pulsed Radiofrequency. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07002944 currently recruiting?

Yes, NCT07002944 is actively recruiting participants. Contact the research team at Yasminasayed.Ys@icloud.com for enrollment information.

Where is the NCT07002944 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07002944 clinical trial?

NCT07002944 is sponsored by Cairo University. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology